Page last updated: 2024-08-24

fluorodeoxyglucose f18 and Neurofibromatosis 2

fluorodeoxyglucose f18 has been researched along with Neurofibromatosis 2 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Anton-Rodriguez, JM; Coope, D; Djoukhadar, I; Evans, DG; Jackson, A; Julyan, P; King, AT; Lewis, D; Lloyd, SKL; Matthews, JC; Russell, D1
Hanemann, CO; Kaempchen, KE; Kaufmann, D; Krause, BJ1

Other Studies

2 other study(ies) available for fluorodeoxyglucose f18 and Neurofibromatosis 2

ArticleYear
[18F]fluorothymidine and [18F]fluorodeoxyglucose PET Imaging Demonstrates Uptake and Differentiates Growth in Neurofibromatosis 2 Related Vestibular Schwannoma.
    Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology, 2019, Volume: 40, Issue:6

    Topics: Adult; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neurofibromatosis 2; Neuroma, Acoustic; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Young Adult

2019
Fludeoxyglucose F 18 positron emission tomography and computed tomography of a giant retroperitoneal schwannoma occurring in a patient with neurofibromatosis type 2.
    Archives of neurology, 2005, Volume: 62, Issue:4

    Topics: Adolescent; Fluorodeoxyglucose F18; Humans; Kidney; Lumbosacral Plexus; Male; Neurilemmoma; Neurofibromatosis 2; Positron-Emission Tomography; Retroperitoneal Neoplasms; Retroperitoneal Space; Spinal Nerve Roots; Tomography, X-Ray Computed; Treatment Outcome

2005